Augmented fifth

Lawsuit Filed Against Goals Plastic Surgery Clinic for Sexual Exploitation of Patient

Retrieved on: 
Wednesday, April 3, 2024
MICHAEL, Malpractice, LaShawn, Betrayal, District court, Krystal, Patient, Risk, Augmented fifth, THOMAS, History, Female, LLP, KIN, Woman, Complaint, Barrel, Behavior, P.C, GLS, Supreme court, Safety, Patient safety, See, Predation, Bluetooth, Nursing

NEW YORK, April 3, 2024 /PRNewswire-PRWeb/ -- Chaffin Luhana LLP has filed a medical malpractice and negligent hiring and supervision case against Goals Plastic Surgery of New York and Dr. Peter Driscoll because of non-consensual sexual contact with a woman at a Goals clinic in New Jersey.

Key Points: 
  • (1:24-CV-02496) a lawsuit against Goals Plastic Surgery, Dr. Sergey Voskin, Dr. Peter Driscoll, and others for medical malpractice in New Jersey, citing non-consensual sexual contact by Driscoll and highlighting past license suspensions.
  • NEW YORK, April 3, 2024 /PRNewswire-PRWeb/ -- Chaffin Luhana LLP has filed a medical malpractice and negligent hiring and supervision case against Goals Plastic Surgery of New York and Dr. Peter Driscoll because of non-consensual sexual contact with a woman at a Goals clinic in New Jersey.
  • Dr. Anthony R. Perkins, of New York, Dr. Sergey Voskin of Brooklyn, and, among others, Goals Aesthetics & Plastic Surgery.
  • "This lawsuit and others seek to ensure that Dr. Driscoll and Goals do not get away with victimizing women in their plastic surgery mill.

Face Expert Dr. Georges J. Samaha Joins Exclusive Haute Beauty Network

Retrieved on: 
Wednesday, January 31, 2024
Augmented fifth, Surgeon, Breast augmentation, Mount Sinai Hospital, Alpha Omega Alpha, Family, Breast, Travel, Plastic surgery, AOA, Rhinoplasty, Patient, Philosophy, Plastic, FDA, Johns Hopkins Hospital, Nobel Prize, Journal, BBL, University, Beauty, Medicine, Textbook, Craniofacial, Mastopexy, Hospital, Dentistry

NEW YORK, Jan. 31, 2024 /PRNewswire-PRWeb/ -- Dr. Georges Samaha is double-board certified by the American Board of Plastic Surgery. He is a diplomate of the American Board of Plastic Surgery as well as a diplomate of the American Board of Surgery. Dr. Samaha has specific interests in various aspects of facial plastic surgery — including deep plane facelift, neck lift, rhinoplasty, and eyelid rejuvenation — as well as breast and body contouring procedures. Patients travel from around the world for the above procedures including breast augmentation, breast lifts, high-definition tummy tucks, natural buttock augmentation using fat transfer known as the Brazilian Butt Lift ("BBL"), and his special natural high-definition liposuction with abdominal etching technique. Dr. Samaha's array of popular procedures can provide patients with beautiful, natural curves and are truly life-changing.

Key Points: 
  • Dr. Georges J. Samaha joins Haute Beauty Network as a face expert representing the Miami, FL market.
  • NEW YORK, Jan. 31, 2024 /PRNewswire-PRWeb/ -- Dr. Georges Samaha is double-board certified by the American Board of Plastic Surgery.
  • He is a diplomate of the American Board of Plastic Surgery as well as a diplomate of the American Board of Surgery.
  • Dr. Samaha has specific interests in various aspects of facial plastic surgery — including deep plane facelift, neck lift, rhinoplasty, and eyelid rejuvenation — as well as breast and body contouring procedures.

Mirum Pharmaceuticals Presents New Data at The Liver Meeting®

Retrieved on: 
Monday, November 13, 2023
Science, Biotechnology, Research, Pharmaceutical, General Health, Health, Infectious Diseases, Clinical Trials, Sleep, Hepatology, MDR3, Self-harm, Safety, Hepatocellular carcinoma, Bilirubin, Cholestasis, AASLD, Liver, Disease, Risk, Cholestatic pruritus, Hematology, Quality of life (healthcare), MYO5B, PFIC, Patient, Publication, Pregnancy, Nature, TJP2, Ascending cholangitis, GI, Hippeastrum mirum, Liver support system, Volixibat, ICP, IBAT, Progressive familial intrahepatic cholestasis, FIC, Augmented fifth, Growth, Doctor of Philosophy, Quality of life, AND, Itch, Medication, MCID, HIV disease progression rates, SBA, Chloride, Pharmaceutical industry, Nursing, Medical imaging, Dietary supplement, Boston, BSEP

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) today announced new data from its LIVMARLI and volixibat programs presented at The Liver Meeting®, the American Association for the Study of Liver Diseases (AASLD) annual meeting in Boston, Massachusetts.

Key Points: 
  • Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) today announced new data from its LIVMARLI and volixibat programs presented at The Liver Meeting®, the American Association for the Study of Liver Diseases (AASLD) annual meeting in Boston, Massachusetts.
  • “PFIC is a chronic, debilitating cholestatic liver disease characterized by elevated bile acids and pruritus so severe that patients can be listed for liver transplant even in the absence of disease progression.
  • These data suggest overall improved liver health with maralixibat treatment in patients with PFIC that can be maintained long-term.
  • No clinically meaningful changes in liver enzyme levels or hematology parameters were observed after volixibat treatment.

Interventional Spine Devices Market to grow by USD 3.07 billion from 2023 to 2028; North America to account for 47% of market growth- Technavio

Retrieved on: 
Monday, November 20, 2023
Phacoemulsification, Osteoporosis, Augmented fifth, Spinal fusion, Abbott Laboratories, Chronic pain, Prevalence, Stryker Corporation, ROW, Spine, Spondylolisthesis, Laboratory, Patient, Research, Otoscope, USD, VCF, Zimmer Biomet, Medtronic, Proclaim!, Trauma, Pain, Scoliosis, Growth, SE, Radiofrequency ablation, Family, Free, Dentistry, Retail, Speciality chemicals, Bookbinding

NEW YORK, Nov. 20, 2023 /PRNewswire/ -- The interventional spine devices market is expected to grow by USD 3.07 billion from 2023 to 2028.

Key Points: 
  • NEW YORK, Nov. 20, 2023 /PRNewswire/ -- The interventional spine devices market is expected to grow by USD 3.07 billion from 2023 to 2028.
  • North America is estimated to contribute 47% to the growth of the global market during the forecast period.
  • Detailed information on factors that will drive the growth of the interventional spine devices market between 2023 and 2028.
  • Growth of the interventional spine devices market across North America, Europe, Asia, and ROW
    Comprehensive analysis of factors that will challenge the growth of interventional spine device market companies.

Female Filmmaker Duo Releases Thriller That Questions Culture's Beauty Obsession

Retrieved on: 
Monday, November 13, 2023
Executive producer, Body dysmorphic disorder, Risk, Clinic, Woman, Health, Augmented fifth, BDD, Life, Amazon, Entertainment, Film industry

ATLANTA, Nov. 13, 2023 /PRNewswire-PRWeb/ -- A new thriller with a unique storyline and surprising plot twist goes behind the operating curtain of an underground cosmetic surgery clinic where a myriad of terrifying encounters await. "Clinic" takes viewers on a suspense-filled journey into a clinic that upends one woman's life forever. The latest movie released by the Atlanta-based female filmmaker duo Aleshia Cowser Jackson and Sharna L. Brown, "Clinic" follows a young single mother who decides to get a Brazilian Butt Lift against professional opinion. What was meant to be a three-hour procedure turns into a fight for her life and the gut-wrenching ordeal is portrayed on screen by Eyeam Cinema. "Clinic" is streaming now on Amazon Prime Video.

Key Points: 
  • The latest movie released by the Atlanta-based female filmmaker duo Aleshia Cowser Jackson and Sharna L. Brown, "Clinic" follows a young single mother who decides to get a Brazilian Butt Lift against professional opinion.
  • "Our films are intended to be both thought-provoking and entertaining, and this film raises some pretty complex questions."
  • – Eyeam Cinema CEO, Aleshia Cowser Jackson
    "We're proud of this film," says Aleshia Cowser Jackson, the founder and CEO of Eyeam Cinema.
  • Thus, our films are intended to be both thought-provoking and entertaining, and this film raises some pretty complex questions."

The Inner Circle Acknowledges, Harshpal Singh, MD, FAANS as a Distinguished Healthcare Professional for his contributions to the Neurological Field

Retrieved on: 
Wednesday, September 27, 2023
Spinal fusion, Icahn School of Medicine at Mount Sinai, University, Education, Tetraplegia, Neurosurgery, Laminectomy, Medical college, Neurology, Corpectomy, Medical College of Georgia, Deformity, Multimedia, Inner circle, Congress, American Board of Commissioners for Foreign Missions, Subarachnoid hemorrhage, Congress of Neurological Surgeons, American Association of Neurological Surgeons, MD, Patient, Mount Sinai School, Nerve, Myelopathy, Sport, Textbook, Neuro, Medical degree, Veterinary medicine, Dentistry, Spine, Augmented fifth, Medicine

ENGLEWOOD CLIFFS, N.J., Sept. 27, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Harshpal Singh, MD, FAANS is acknowledged as a Distinguished Healthcare Professional for his contributions to the Neurological Field.

Key Points: 
  • ENGLEWOOD CLIFFS, N.J., Sept. 27, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Harshpal Singh, MD, FAANS is acknowledged as a Distinguished Healthcare Professional for his contributions to the Neurological Field.
  • He completed a residency at Mount Sinai School of Medicine where he served as Chief Resident.
  • The doctor is also a specialist in spinal fusion; corpectomy; vertebroplasty; kyphoplasty; laminectomy; and difficult revision spinal surgery.
  • Aside from his professional pursuits, the doctor enjoys funding programs that distribute sports equipment to the disadvantaged in Punjab, India.

New York Consulting Services Takes a Stand Against Rising Plastic Surgery Complications and Deaths

Retrieved on: 
Tuesday, September 5, 2023
Rash, Al Jazeera, NYCS, Death, Woman, Augmented fifth, Multimedia, Patient, Education, Patient safety, Safety, BBL, Dentistry, Nursing

However, in recent years, we have seen countless reports of complications and patient fatalities – with many coming from the country's premiere destination for plastic surgery – Miami, Florida!

Key Points: 
  • However, in recent years, we have seen countless reports of complications and patient fatalities – with many coming from the country's premiere destination for plastic surgery – Miami, Florida!
  • A recent Al Jazeera feature has pointed out the rash of complications and patient deaths, highlighting the importance of making informed choices in this evolving industry.
  • New York Consulting Services provides patients with the education and guidance they need to get the best and safest surgical experience possible.
  • Al Jazeera's news feature sheds light on the increase in surgical complications and patient deaths across Miami, the nation's most popular plastic surgery destination.

Calvac Paving is Officially Certified as a Woman-Owned Small Business

Retrieved on: 
Thursday, August 24, 2023
Certification, Augmented fifth, WOSB, War Office Selection Boards, SAN, Interior design

SAN JOSE, Calif., Aug. 24, 2023 /PRNewswire/ -- Tami Adam, Owner of Calvac Paving, is pleased to announce that her company has been officially certified as a Woman-Owned Small Business with both the federal and state governments.

Key Points: 
  • SAN JOSE, Calif., Aug. 24, 2023 /PRNewswire/ -- Tami Adam, Owner of Calvac Paving, is pleased to announce that her company has been officially certified as a Woman-Owned Small Business with both the federal and state governments.
  • To read more about the certification and what it means for Calvac Paving and its clients, please visit https://www.calvacpaving.com/calvac-paving-is-officially-certified-as-a-... .
  • As Owner Tami Adam noted, the process to become certified as a Woman-Owned Small Business was demanding and comprehensive.
  • While the recent certification as a Woman-Owned Small Business is not the focus for Calvac Paving's visibility and growth—the company's outstanding reputation for almost 50 years speaks for itself—Tami is excited to connect with other WOSBs.

Safe Orthopaedics announces the publication of a biomechanical study on Sycamore

Retrieved on: 
Tuesday, August 8, 2023
Surgeon, CET, Vertebral compression fracture, Osteoporosis, Vertebra, Professor, Augmented fifth, Journal, Patient, Fracture, Bone fracture, Dentistry, Adhesive, Spine, Sycamore, Vertebral augmentation

Éragny-sur-Oise, Fleurieux sur l’Arbresle, France, le 07 août 2023 à 17h30 CET – Safe (FR001400F1V2 – ALSAF), french group specialized in the design, manufacturing and distribution of ready-to-use medical devices for Spine surgeries, especially safe for vertebral fracture treated in emergency, announces the publication of a biomechanical study of Sycamore and over 160 patients treated with Sycamore.

Key Points: 
  • Éragny-sur-Oise, Fleurieux sur l’Arbresle, France, le 07 août 2023 à 17h30 CET – Safe (FR001400F1V2 – ALSAF), french group specialized in the design, manufacturing and distribution of ready-to-use medical devices for Spine surgeries, especially safe for vertebral fracture treated in emergency, announces the publication of a biomechanical study of Sycamore and over 160 patients treated with Sycamore.
  • Leaded by Professor Jean-Charles Le Huec, the study compares the biomechanical behavior of vertebrae treated by “Dowelplasty”, a new surgical technique using a pedicle anchored device Sycamore (commercial name by Safe Orthopedics) with a traditional kyphoplasty system.
  • The study is published in the Journal of Experimental Orthopedics.
  • In comparison with the Kyphoplasty, Sycamore shows a significant increase of the compression strength (373 N ; IC à 95% ; – 331 N versus – 1076 N for Sycamore).

Data from Mirum’s LIVMARLI Studies Presented at ESPGHAN Annual Meeting

Retrieved on: 
Friday, May 19, 2023
Biotechnology, Pharmaceutical, Health, Clinical Trials, CXS, Hippeastrum mirum, CET, SBA, Cholesterol, Research, Publication, AdventHealth, Doctor of Philosophy, Medication, Xanthoma, Hypercholesterolemia, Professor, Patient, Fracture, Augmented fifth, Itch, Bilirubin, Annual general meeting, Bile, Gastrointestinal bleeding, International Society for Pediatric and Adolescent Diabetes, Liver, Poster, IBAT, Alagille syndrome, GI, PFIC, Cholestatic pruritus, Safety, Pharmaceutical industry, Nightclub, Dietary supplement, ALGS, Nutrition, Gastroenterology

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced data presented during the 55th European Society for Pediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting.

Key Points: 
  • Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced data presented during the 55th European Society for Pediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting.
  • Among the data presented were four oral and three poster presentations featuring analyses from LIVMARLI® (maralixibat) oral solution clinical studies.
  • The analysis evaluated the impact of LIVMARLI on xanthomas using data from ALGS studies.
  • The data showed that LIVMARLI was well-tolerated in a real-world setting with lower rates of adverse events than described in clinical trials.